Is there a difference between an AATB accredited tissue bank and a tissue distributor?

Yes. A tissue bank typically recovers, screens, processes, and stores human tissue, whereas a distributor markets and ships the finished product to medical practices. When vetting a distributor, you must verify that the underlying processing lab holds active AATB accreditation and confirm whether the distributor ships directly from that accredited facility or maintains its own validated, compliant storage facility.

How can a practice manager independently verify FDA registration for tissue allografts?

Administrators can use the FDA's public Human Cell and Tissue Establishment Registration (HCTERS) database online. By entering the legal name of the processing facility or distributor, you can confirm whether their registration is active, view the types of tissues they are registered to handle, and verify the date of their last update.

What documents should accompany every shipment of human tissue allografts?

Every shipment should include a packing slip with specific lot numbers and expiration dates, a package insert detailing preparation and storage instructions, and a tissue tracking or utilization record card. Additionally, the distributor should make the lot-specific Certificate of Analysis (CoA) or Certificate of Compliance readily available for your clinic's permanent records.

Who is responsible if a cryopreserved allograft thaws during transit?

Liability depends on the terms of sale established with your distributor. Reputable distributors use validated shipping containers designed to maintain cryogenic temperatures beyond standard overnight transit times and will replace product compromised by carrier delays, provided your staff documents the temperature excursion immediately upon receipt.

How long must a medical practice retain tissue tracking records?

Under federal HCT/P regulations (21 CFR Part 1271) and standard accreditation guidelines, facilities must maintain records that allow complete tracking of tissue from the donor to the recipient or final disposition. Most compliance frameworks and tissue bank agreements require clinics to retain these lot logs and patient charting records for at least ten years after the date of administration or expiration.

Practice Operations · For practice managers

How to Vet an AATB Accredited Tissue Allograft Distributor

Published November 1, 2026

Primary Regulatory Framework: 21 CFR Part 1271
Core Verification Pillars: 3 Levels
Standard Record Retention: 10 Years

To vet an AATB accredited tissue allograft distributor, practice administrators must independently verify the source tissue bank's active accreditation with the American Association of Tissue Banks (AATB), confirm current FDA Establishment Registration under 21 CFR Part 1271, and audit the distributor's cold-chain logistics and lot-level traceability protocols. Because distributors frequently act as intermediaries rather than the primary processors, due diligence requires reviewing documentation for both the customer-facing vendor and the underlying manufacturing facility. Establishing a formal vendor qualification file before purchasing amniotic, umbilical cord, or Wharton's Jelly products protects the clinic from regulatory exposure and compromised inventory.

Why Rigorous Vendor Qualification Matters in Regenerative Medicine

For a medical practice manager or healthcare administrator, onboarding a new vendor for regenerative biologics carries significantly higher operational and compliance stakes than sourcing standard medical surgical supplies. Human cells, tissues, and cellular and tissue-based products (HCT/Ps) are subject to strict federal and state oversight.

In the regenerative medicine space, a critical distinction often gets blurred during sales presentations: the difference between the processing tissue bank and the commercial distributor. A distributor may market products as "AATB accredited," when in reality, the accreditation belongs to the third-party laboratory that recovered and processed the tissue, while the distributor handles sales, storage, and fulfillment. If a distributor fails to maintain proper storage temperatures or cannot produce a clean chain-of-custody record during an audit, the purchasing clinic bears the operational disruption and liability risk.

Whether your practice serves patients in orthopedics or aesthetics, establishing a standardized vetting protocol ensures that every vial or graft entering your facility meets uncompromising safety, legal, and quality benchmarks.

Step-by-Step Compliance and Procurement Checklist

When evaluating how to vet an AATB accredited tissue allograft distributor, administrators should require a complete compliance packet before signing a purchasing agreement or placing an initial order. Use the following checklist to audit prospective partners:

Verify Active AATB Accreditation Directly: Ask the distributor for the exact legal name of the processing tissue bank and the distributor's own corporate entity name. Cross-reference both against the public directory of accredited banks maintained by the American Association of Tissue Banks. Confirm whether the distributor holds its own accreditation for tissue distribution or relies solely on drop-shipping directly from an accredited processor.
Confirm FDA Establishment Registration (FEI): Require a copy of the current FDA Establishment Registration and Listing for Human Cells, Tissues, and Cellular and Tissue-Based Products. Verify this status independently in the FDA’s public electronic database to ensure the registration is active and lists the specific tissue types (e.g., amniotic membrane, umbilical cord blood, Wharton's Jelly) your clinic intends to purchase.
Audit State Licensing and Distribution Credentials: Many states require specific wholesale distributor, device, or tissue bank permits to ship biologics across state lines or within a state. Verify that the distributor holds active licensure in their home state and any required permits for your clinic's jurisdiction. For example, Dallas Regenerative Solutions operates as a licensed Texas medical device distributor (License #1002308), providing transparent regulatory standing for partner practices.
Clarify the Regulatory Pathway (361 vs. 351): Request formal documentation stating the regulatory classification of each product. Products marketed under Section 361 of the Public Health Service (PHS) Act must meet specific criteria, including minimal manipulation and homologous use. Review the distributor's marketing literature and package inserts; red-flag any vendor that makes unapproved therapeutic drug claims or encourages off-label clinical promotion that violates FDA guidance.
Examine Donor Eligibility and Infectious Disease Testing Standards: Request a sample Certificate of Analysis (CoA) or Certificate of Compliance for a representative lot. The documentation must confirm that the donor was screened for relevant communicable disease agents and diseases (RCDADs) in a CLIA-certified and FDA-registered testing laboratory, using FDA-licensed, approved, or cleared donor screening tests.
Evaluate Cold-Chain Logistics and Excursion Policies: For cryopreserved allografts, inquire about the exact shipping methodology (dry ice vs. liquid nitrogen dry vapor shippers), validated transit times, and courier contingencies. Obtain a written Standard Operating Procedure (SOP) detailing who bears the financial cost if a shipment experiences a temperature excursion due to carrier delays.
Review Adverse Event and Recall Traceability Protocols: Under federal regulations, HCT/Ps require strict tracking from the donor to the final recipient (or final disposition). Ask the distributor to demonstrate how they manage lot-level traceability, how tissue utilization cards are registered, and how quickly they notify clinics in the event of a field corrective action or recall.

Evaluating Operational Fit, Inventory, and Cost Per Treatment

Once a distributor passes the regulatory and quality screen, the practice manager must evaluate how the vendor’s operational model impacts clinic cash flow and daily workflow.

Cold-Chain Receiving and On-Site Storage

Different tissue allografts carry distinct storage requirements—ranging from ambient room-temperature amniotic membranes to cryopreserved cellular tissues requiring ultra-low temperature freezers or liquid nitrogen (LN2) dewars. If your practice does not own ultra-low storage equipment, you must rely on just-in-time (JIT) delivery. Vet the distributor on their cutoff times for overnight shipping, minimum order quantities (MOQs), and whether they restrict shipment days (such as Monday through Wednesday) to prevent weekend carrier stranding.

Transparent Pricing and Cost Per Treatment

Hidden logistics fees rapidly erode procedure margins. When calculating your true cost per treatment, look beyond the per-vial or per-cc unit price. Account for dry ice fees, specialized cryogenic hazardous shipping surcharges, container return shipping costs (for reusable LN2 dry shippers), and restocking fees. A reliable distributor provides a comprehensive fee schedule upfront so administrators can build accurate financial models for their clinical service lines.

Clinical Perspective: What Physicians Need from Your Vetting Process

While practice administrators focus on chain of custody, invoicing, and regulatory documentation, the treating physicians—such as regenerative medicine doctors and pain management specialists—rely on the procurement process to safeguard clinical consistency and patient safety. When presenting a vetted distributor to your medical director or physician partners, ensure your evaluation addresses these clinical priorities:

Processing Methodology and Tissue Integrity: Clinicians need transparency regarding how the tissue is processed and preserved. Ask the distributor for technical monographs explaining the sterilization or aseptic processing methods (e.g., terminal sterilization levels, use of cryoprotectants like DMSO vs. DMSO-free formulations) so physicians understand the structural properties of the allograft they are handling.
Lot-to-Lot Consistency: Physicians expect predictable handling characteristics—such as viscosity, resuspension ease, and syringeability through specific needle gauges. Accredited processors follow strict Standard Operating Procedures that minimize batch-to-batch variability, which directly supports smoother bedside preparation.
Clean Clinical Documentation: Treating clinicians require clear, compliant package inserts that outline preparation instructions, storage duration post-thaw, and contraindications without straying into unsupported clinical promises. Partnering with a distributor that separates sales hype from objective tissue characterization protects the physician’s medical license.

What This Means for Your Practice

Transitioning your regenerative procurement from ad-hoc ordering to a structured vendor qualification framework protects both your patients and your business entity. Take these concrete next steps to standardize your biologics supply chain:

Build a Vendor Qualification Binder: Create a digital and physical compliance file for every biologics vendor your clinic uses. Store active copies of their AATB certificates, FDA establishment registrations, state distributor licenses, and sample Certificates of Analysis, and set calendar reminders to renew these documents annually.
Standardize Receiving Logs: Implement a mandatory receiving checklist for front-desk or back-office clinical staff. Every biologic delivery should be logged upon arrival with the date, time, lot number, expiration date, visual inspection of dry ice or temperature indicators, and staff signature.
Consolidate with Vetted Partners: Working with an established, licensed distributor that supplies both compliant allografts and complementary medical supplies streamlines invoicing, reduces freight overhead, and gives your staff a single point of accountability.

If your practice is currently auditing its regenerative supply chain or expanding its clinical offerings, contact our team for a consultation on compliant biologics sourcing and practice integration.

Frequently asked questions

Is there a difference between an AATB accredited tissue bank and a tissue distributor?: Yes. A tissue bank typically recovers, screens, processes, and stores human tissue, whereas a distributor markets and ships the finished product to medical practices. When vetting a distributor, you must verify that the underlying processing lab holds active AATB accreditation and confirm whether the distributor ships directly from that accredited facility or maintains its own validated, compliant storage facility.
How can a practice manager independently verify FDA registration for tissue allografts?: Administrators can use the FDA's public Human Cell and Tissue Establishment Registration (HCTERS) database online. By entering the legal name of the processing facility or distributor, you can confirm whether their registration is active, view the types of tissues they are registered to handle, and verify the date of their last update.
What documents should accompany every shipment of human tissue allografts?: Every shipment should include a packing slip with specific lot numbers and expiration dates, a package insert detailing preparation and storage instructions, and a tissue tracking or utilization record card. Additionally, the distributor should make the lot-specific Certificate of Analysis (CoA) or Certificate of Compliance readily available for your clinic's permanent records.
Who is responsible if a cryopreserved allograft thaws during transit?: Liability depends on the terms of sale established with your distributor. Reputable distributors use validated shipping containers designed to maintain cryogenic temperatures beyond standard overnight transit times and will replace product compromised by carrier delays, provided your staff documents the temperature excursion immediately upon receipt.
How long must a medical practice retain tissue tracking records?: Under federal HCT/P regulations (21 CFR Part 1271) and standard accreditation guidelines, facilities must maintain records that allow complete tracking of tissue from the donor to the recipient or final disposition. Most compliance frameworks and tissue bank agreements require clinics to retain these lot logs and patient charting records for at least ten years after the date of administration or expiration.

Continue reading

How to Vet Biologic Supplier Certificate of Analysis Testing
A structured procurement framework for practice managers evaluating biologic vendor documentation, third-party lab testing, and lot-specific compliance.
FDA Compliance Checklist for Clinics Purchasing Exosomes
A structured operational guide and compliance checklist for medical practice managers evaluating exosome vendors, regulatory frameworks, and clinic risk management.
PRP Kit Procurement Cost Comparison: Closed vs Open Systems
Evaluating PRP systems requires looking beyond the upfront consumable price to analyze technician labor, regulatory compliance, and contamination risk. Here is how practice managers compare closed and open PRP architectures.
How to Vet Regenerative Medicine Biologic Distributors
A structured procurement framework for medical practice managers to evaluate biologic distributors on regulatory standing, tissue bank credentials, and supply chain integrity.